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Background: Tarantulas (Theraphosidae) represent an important source of novel biologically active compounds
that target a variety of ion channels and cell receptors in both insects and mammals. In this study, we evaluate and
compare the pharmacological activity of venoms from three taxonomically different theraphosid spiders bred in
captivity: Poecilotheria regalis, an aggressive arboreal tarantula from southeastern India; Ceratogyrus darlingi, an aggressive
tarantula from southern Africa; and Brachypelma epicureanum, a docile tarantula from the Yucatan dry forest of Mexico.
Prior to this study, no research had been conducted with regard to the composition and pharmacological activity of
these venoms.
Methods: The pharmacological characterization of the venoms was described for the first time by the assessment of their
toxicity in crickets (LD50) along with their nociceptive (by using the formalin test), hyaluronidase, phospholipase
A2, edematogenic and caseinolytic activity.
Results: P. regalis and B. epicureanum venoms induced a similar lethal effect on crickets (LD50 = 5.23 ± 3.1 and
14.4 ± 5.0 μg protein/g 48 h post-injection, respectively), whereas C. darlingi venom (119.4 ± 29.5 μg protein/g
48 h post-injection) was significantly less lethal than the other two venoms. All three venoms induced similar
edematogenic activity on rats but did not induce nociceptive behavior. The assessment of enzymatic activity indicated
that P. regalis venom induces significantly higher hyaluronidase activity (27.6 ± 0.9 TRU/mg) than both C. darlingi
(99.7 ± 1.9 TRU/mg) and B. epicureanum (99.6 ± 1.6 TRU/mg); these latter venoms did not display phospholipase
A2 or caseinolytic activity.
Conclusions: This study demonstrates that these theraphosid spiders of different habitats produce venoms with
different activities. P. regalis venom displays a high level of hyaluronidase activity, which may be associated with
its potentially medically significant bite.
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The Theraphosidae family (phylum Arthropoda, class
Arachnida, order Araneae, suborder Mygalomorphae) is a
sizable group of large spiders that are also called tarantu-
las. Their venoms are mainly composed of peptides and
proteins that target a variety of ion channels and cell re-
ceptors in both insects and mammals. Other components
usually found in their venoms are nucleotides, free amino
acids, neurotransmitters, polyamines and salts [1]. Due to
the diverse mixture of components, tarantula venoms rep-
resent an important source of novel biologically active
compounds that are potentially valuable for the develop-
ment of therapeutic agents, tools for pharmacological re-
search, and insecticidal peptides for potential use in
agriculture [2–4].
To date, approximately 975 species of tarantulas (in 128
genera) have been recognized, which are found in several
ecological niches worldwide, and it can be expected that
many new species have yet to be described [5]. A total of
226 proteinaceous toxin sequences have been described to
date from approximately 20 theraphosid species, the major-
ity of which are small peptides that are ion-channel modu-
lators [6]. Therefore, there is a significant interest in the
study of the venoms of Theraphosidae species, not only be-
cause they constitute a potential source of valuable biomol-
ecules, but also because they represent a large group that is
relatively unexplored. In addition, the considerable size of
these spiders permits easier venom extraction.
Tarantulas have become popular pets and the availability
of several species has been facilitated by captive breeding.
In this work, we focus on the pharmacological activity of
the venoms from three taxonomically different theraphosid
spiders widely kept and bred in captivity: two Old World
tarantulas (Poecilotheria regalis and Ceratogyrus darlingi)
and a new world tarantula (Brachypelma epicureanum).
P. regalis, commonly referred to as the “Indian orna-
mental tree spider”, is an arboreal tarantula from
southeastern India and it is considered aggressive and
very fast. It is also one of the most popular tarantulas
for collectors. C. darlingi, commonly called the African
rear-horned Baboon, is an aggressive tarantula from
southern Africa. Its venom is believed to be no more
than mildly toxic to humans and it is the most com-
mon Ceratogyrus species held in captivity [5]. Finally,
B. epicureanum is a tarantula from the Yucatan dry for-
est of Mexico and it is considered nonaggressive [5, 7].
In general, tarantulas are not harmful to humans and
there is no record of human deaths resulting from a bite
by these spiders [1, 8]. However, it is clear that some
venoms are more toxic than others and may cause ser-
ious discomfort that might persist for several days. Some
reports of tarantula bites suggest that the toxicity of Old
World species is higher than that of the New World
species, especially the members of the genus Poecilotheria[9, 10]. In a recent review of the literature on bites of spe-
cies of this genus, it was found that a delayed onset of se-
vere muscle cramps lasting for days is characteristic of
Poecilotheria bites; other registered symptoms were local
swelling, erythema, and moderate to severe pain [11].
Prior to this study, there had been no research conducted
regarding the composition and pharmacological activity of
the venoms of P. regalis, C. darlingi, and B. epicureanum.
Thus, the aim of the current work was to provide quantita-
tive information on the toxicology of these venoms in order
to determine their pharmacological potential.
Methods
Reagents
Hyaluronic acid sodium salt from Streptococcus equi, hyal-
uronidase from bovine testes type IV-S, hexadecyltrimethy-
lammonium bromide, protease from Streptomyces griseus,
and carrageenan were purchased from Sigma (USA). Re-
fined chemicals used for buffer preparations were pur-
chased from J. T. Baker (USA). All reagents used in the
determination of protein concentration and electrophoretic
analysis were obtained from Bio-Rad (USA).
Spiders
The adult female spiders (80–90 mm) bred in captivity
used in this work were obtained from the Mexican De-
partment of the Environment and Natural Resources-
Management and Preservation Unit (SEMARNAT-
UMA-IN-0062-JAL). All spiders were kept individually
in plastic containers with water ad libitum and were fed
weekly with crickets (Acheta domestica).
Venom extraction
The spiders were immobilized by placing them in a small
receptacle in a chloroform atmosphere for 15 min and then
they were attached by the cephalothorax to a hand-made
holder. The fangs were raised and positioned in a 1.5 mL
microcentrifuge tube, ensuring that there was not any con-
tamination with digestive fluids and saliva. Then, electrosti-
mulation was applied with a pair of modified electrodes
using an electrophoresis power supply (PowerPac Basic
Power Supply Bio-Rad, USA) at 10–15 V. Electrodes were
positioned within the fissure between the chelicerae and
the cephalothorax, and stimulus was applied for two sec-
onds with a three-second interval between shocks for
1 min. The collecting tubes were weighed before and after
the venom extraction in order to estimate the weight of the
liquid venom obtained. After the extraction, the venom was
centrifuged and stored at −70 °C until it was used. Extrac-
tion was performed monthly in order to allow sufficient
time for the tarantulas to replenish their venom supply.
Analysis of venom profiles by electrophoresis was done in-
dividually and differences were not observed between speci-
mens of the same species or between successive extractions
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or seven extractions were used to form a pool of venom
from each species for the biological assessments.
Protein quantification
The protein content of the venoms was determined by
the Bradford assay [12], using a standard curve prepared
with lyophilized bovine serum albumin.
Toxicity in crickets
The venom toxicity was assessed by determining the me-
dian lethal dose (LD50) in crickets (Acheta domestica pur-
chased from Maskota SA de CV, Mexico) of undetermined
sex weighing 190–210 mg by a previously described
method [13]. Briefly, venoms were assessed by thoracic in-
jection into crickets (n = 5, for each venom dose) at several
doses (1, 3.2, 10, 31.6, 100, and 316 μg protein/mL). All
venoms were dissolved in insect saline composed of
200 mM NaCl, 3.1 mM KCl, 5.4 mM CaCl2, 4 mM MgCl2,
2 mM NaHCO3, 0.1 mM Na2HPO4, pH 7.2. The injection
volume for all crickets, including the controls that received
insect saline, was 10 μL. Injections were performed using a
0.3 mL-gauge insulin syringe (B-D Ultra-Fine, Terumo
Medical Corporation, USA). After the injection, the crickets
were placed in small plastic containers with food and water.
Mortality was scored at 24 and 48 h post-injection. The
LD50 values were interpolated by fitting log dose–response
curves using non-linear regression analysis in Prism 5.0
(GraphPad Software, Inc., USA) and reported as the
mean ± SEM of three replicates.
Formalin test
Acute neurogenic and chronic inflammatory nociception
were measured using the rat paw formalin test as de-
scribed by Dubuisson and Dennis [14] with some modi-
fications. Three quantities of each venom (5, 10, and
20 μg protein/paw) were dissolved in 50 μL of sterile sa-
line solution (0.9 % NaCl) and injected subcutaneously
into the right dorsal hind paw of male Wistar rats
weighing 100–120 g (n = 3/group). The positive control
group received 50 μL of 2.5 % formalin, and the negative
group received 50 μL of saline solution through the
same route of administration. During the test, each rat
was placed in a transparent glass container and nocicep-
tive behavior was quantified by counting the time of
licking, flinching, and lifting of the injected hind paw.
Measurements were made in two phases: the first phase
(neurogenic) was evaluated during the period from 0 to
10 min after injection, and the second phase (inflamma-
tory) was from 10 to 50 min after injection.
Edematogenic activity
To assess the edematogenic activity of venoms, rat paw
edema was measured with a manual hydroplethysmometeras previously described [15]. After subplantar injection of
50 μL of venom (40 μg protein/paw) on the right hind paw
of male Wistar rats weighing 100–120 g (n = 3/group), the
rat paw edema was measured every 10 min in the first hour
and every 30 min in the second hour. The positive control
group received 100 μL of 1 % carrageenan solution pre-
pared with distilled water, and the negative group received
50 μL of saline solution through the same route of
administration.
Enzymatic activity
The hyaluronidase activity was determined according to
a turbidimetric method [16]. Briefly, different concentra-
tions of venoms (1, 2.5, 5, 7.5, 10, 15, 20, and 25 μg pro-
tein/mL), diluted in 150 μL of buffer (0.2 M sodium
acetate, pH 6.0, containing 0.15 M NaCl), were incu-
bated with 100 μL of substrate (1 mg of hyaluronic acid
sodium salt from Streptococcus equi in 1 mL of acetate
buffer) at 37 °C for 15 min. After the incubation period,
1 mL of hexadecyltrimethylammonium (2.5 %) in 2 %
NaOH was added to the samples. The resulting turbidity
was read at 400 nm in a microplate spectrophotometer
(Benchmark Plus, Bio-Rad, USA) after 30 min of incuba-
tion at room temperature. As the reference for hyaluron-
idase activity, hyaluronidase from bovine testes type IV-S
was used at the same concentrations as the venoms. The
enzymatic activity was expressed as mean ± SEM (n = 3)
in turbidity reducing units (TRU)/mg. One unit of activ-
ity corresponded to the amount of enzyme that pro-
duced a 50 % reduction in turbidity caused by 0.1 mg of
substrate under the conditions described above.
In order to detect possible phospholipase A2 activity in
the venoms (10 μg of protein), a secretory colorimetric
assay kit (Cayman Chemical, USA) was used. This assay
uses the 1,2-dithio analogue of diheptanoyl phosphatidyl-
choline as substrate. Free thiols generated upon hydrolysis
of the thioester bond at the sn-2 position by phospholipases
were detected using DTNB [(5,5′-dithio-bis-(2-nitrobenzoic
acid)]. Color changes were monitored by a Benchmark Plus
microplate spectrophotometer (Bio-Rad, USA) at 414 nm
by sampling every minute for ten minutes. For this colori-
metric assay, a phospholipase A2 from bee venom was used
as the control. Phospholipase A2 activity was expressed as
μmol of hydrolyzed substrate/minute/mg of protein.
In addition, caseinolytic activity was assayed in order to
detect possible protease activity in the venoms. It was
assayed according to a previously described method [17].
Aliquots (0.4 mL) of 2 % casein in 0.2 M Tris–HCl buffer
(pH 7.5) were incubated with different quantities of venom
(1, 10, 20, 30, 50, and 100 μg protein/mL) at 37 °C for
30 min. The reaction was stopped by adding 1.5 mL of
0.44 M tricholoacetic acid and allowed to stand for 30 min.
The mixture was centrifuged at 1500 × g for 15 min. An ali-
quot (1 mL) was mixed with 2.5 mL of 0.4 M sodium
Table 1 LD50 values estimated from injection of P. regalis, C.
darlingi, and B. epicureanum venoms into crickets
Venoms Time post-injection
24 hours 48 hours
P. regalis 20.6 ± 6.2 5.23 ± 3.1
C. darling 119.4 ± 29.5 120.2 ± 32.3
B. epicureanum 31.5 ± 9.6 14.4 ± 5.0
Values represent the mean ± standard error (n = 3)
Fig. 1 Comparison of LD50 values estimated from the injection of P.
regalis (Prv), C. darlingi (Cdv), and B. epicureanum (Bev) venoms into
crickets. Values represent the mean ± standard error (n = 3). *Significant
difference (p < 0.05)
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color developed was read at 660 nm. The reference for pro-
tease activity was a protease from Streptomyces griseus. Ac-
tivity was expressed as μmol substrate/minute/mg of
protein.
SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Electrophoresis was performed as previously described
[18]. Samples were diluted 1:1 in a sample buffer (Bio-
Rad, USA, Cat # 161–0737). Samples under reducing
conditions were diluted 1:1 in a sample buffer containing
β-mercaptoethanol and heated at 95 °C for 5 min. Then,
18 and 14 % polyacrylamide gels, loaded with 15 μg of
protein, were electrophoresed at 120 V for 2 h at 4 °C,
using Tris-Glycine buffer (25 mM Tris, 192 mM glycine,
pH 8.3; Bio-Rad, USA, Cat # 161–0734). Protein bands
were visualized using Coomasie brilliant blue R-250
staining solution (Bio-Rad, USA, Cat # 161–0437). Mo-
lecular masses were determined by comparison with a
broad-range polypeptide standard (Bio-Rad, USA, Cat #
161–0318).
Ethics committee approval
The animal utilization was approved by the Committee
of Bioethics of the School of Medicine, UAQ.
Results
Venom yield
B. epicureanum specimens yielded more venom (14.7 ±
2.6 mg of liquid/spider; n = 6) than P. regalis (8.7 ± 1.1 mg
of liquid/spider; n = 6) and C. darlingi (4.0 ± 0.1 mg of li-
quid/spider; n = 7) specimens. For B. epicureanum the pro-
tein concentration was 3.2 ± 0.3 % of the venom weight,
while for P. regalis it was 5.9 ± 0.7 %, and 16.3 ± 2.4 % for
C. darlingi.
Toxicity on crickets
The results of the insecticidal activity on crickets showed
that the LD50 values of the venoms of P. regalis and B. epi-
cureanum were similar and the lethality of both venoms
increased with time. The venom of C. darlingi was signifi-
cantly less lethal than the other venoms (Table 1, Fig. 1).
As for P. regalis and B. epicureanum venoms, it was ob-
served that doses equal to or higher than 10 μg protein/g
induced paralysis within 2 min, while doses equal to or
higher than 31.6 μg protein/g of C. darlingi venom in-
duced paralysis within 10 min. However, all crickets para-
lyzed with C. darlingi venom at 31.6 μg protein/g
completely recovered after 24 h.
Formalin test
The results obtained with this test showed that in both
phases (at doses of 5, 10, and 20 μg/rat hind-paw) the
venoms of P. regalis, C. darlingi, and B. epicureanum didnot induce nociceptive behavior in rats when compared to
the negative control (saline solution). On the contrary, the
formalin group was significantly different from all experi-
mental groups and the negative control in the first and sec-
ond phases (Fig. 2).
Edematogenic activity
Assessment of the venoms’ edematogenic activity by
subplantar injection of 40 μg of protein/rat showed that
they induce a similar time-dependent increase in paw
volume (Fig. 3). The maximum responses were observed
at 10 min after administration, decreasing at approxi-
mately 60 min. However, P. regalis venom induced an
evident redness immediately after administration. Carra-
geenan, used as a positive control, induced an increase
in paw volume similar to that induced by the venoms
but it did not decrease during the experiment. The nega-
tive control (50 μL of saline solution) did not induce a
detectable response.
Enzymatic activity
The hyaluronidase activity of P. regalis venom (27.6 ± 0.9
TRU/mg) was significantly higher than that of C. darlingi
(99.7 ± 1.9 TRU/mg) and B. epicureanum (99.6 ± 1.6 TRU/
mg). The hyaluronidase from bovine testes type IV-S, used
Fig. 2 Formalin test for assessment of the nociceptive activity in rats of a P. regalis, b C. darlingi, and c B. epicureanum venoms at three different doses (5,
10, and 20 μg protein/paw). Nociceptive behavior in phase 1 (0–10 min post-injection) and phase 2 (10–50 min post-injection) was scored as the amount
of time spent licking the injected paw. *Significant difference when compared with the negative control injected with saline solution (p< 0.05)
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TRU/mg under these conditions. The venom of P. regalis
reached maximum activity at a concentration of 7.5 μg/mL,
while the other venoms showed maximum activity between
20 and 25 μg/mL (Fig. 4). As expected, it was found that
the venoms do not display phospholipase A2 or caseinolytic
activity. In these assays, a phospholipase A2 from bee
venom displayed an activity of 3.18 ± 1.0 μmol/minute/mgand a protease from Streptomyces griseus displayed an activ-
ity of 980.4 ± 5.2 μmol/minute/mg.
SDS-PAGE analysis
Analysis by electrophoresis provides a preliminary overview
of the proteins present in the venoms. Cdv and Prv profiles
do not show important differences under reducing and not
reducing conditions, and it is evident that these venoms
Fig. 3 Volume of rat paw edema induced by subplantar injection of 40 μg of P. regalis (Prv), C. darlingi (Cdv), and B. epicureanum (Bev) venom protein. The
positive control group received 100 μL of 1 % carrageenan solution, while the negative control group received 50 μL of saline solution (this did not induce
detectable volume changes). Values represent the mean ± standard error (n= 3)
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of mass: 2–15 kDa and ~40 to ~100 kDa. In contrast,
Bev profile evidently change under reducing conditions
(Fig. 5a).
Discussion
The relative toxicity of tarantula venoms is extremely
variable. These spiders’ typical prey mainly consists of
insects and other arthropods, but the venoms from some
species have been reported to be lethal to pigeons,
guinea pigs, rabbits, mice, rats, amphibians, snakes, liz-
ards, and dogs [1, 8]. It is important to consider that the
venom of each tarantula contains a specific mixture of
components that bind to targets and may vary consider-
ably, which was probably an evolutionary outcome that
depended on the diversity of prey species in their envir-
onment. A comparative study on mice, using the venoms
of 55 theraphosid spiders from several geographic areas,Fig. 4 Comparison of hyaluronidase activity displayed in P. regalis (Prv),
C. darlingi (Cdv), and B. epicureanum (Bev) venoms. Hyaluronidase from
bovine testes type IV-S was used as a positive control. Values represent
the mean ± standard error (n= 3)produced results that suggest an apparent higher toxicity
of venoms from arboreal genera such as Heteroscodra
(native to Africa), Stromatopelma (native to Africa), and
Poecilotheria (native to Sri Lanka and India) [1].
In this study, we found that P. regalis venom was slightly
more lethal to crickets than that of B. epicureanum and sig-
nificantly more lethal than C. darlingi venom. The higher
toxicity of P. regalis venom could be an adaptive advantage
used to rapidly paralyze and kill prey in an aerial environ-
ment. The fact that the venom from the Mexican tarantula
was more effective in killing crickets than the venom from
the aggressive African tarantula is consistent with other
studies. For example, it was found that the venoms from
the Mexican tarantulas Brachypelma harmorii and B. albi-
ceps were slightly more lethal to crickets than the venoms
of several Australian tarantulas [19].
An interesting observation in the assessment of the in-
secticidal activity of these venoms was the capacity of C.
darlingi venom to induce reversible paralysis. It is well
known that several venomous animals produce toxins that
modulate the activity of ion channels in order to capture
their prey. Tarantula venoms include peptide neurotoxins
that consist of 33–41 amino acid residues with three disul-
fide bridges that form an inhibitor cystine knot motif, de-
fined as an antiparallel β-sheet stabilized by a cystine knot
[1, 6, 20]. Many of these neurotoxins work together to pro-
voke a characteristic paralysis on several types of prey.
At present, 27 of the 95 neurotoxins from tarantula
venoms listed in ArachnoServer target voltage-gated so-
dium (Nav) channels, most of them acting by inhibiting in-
activation. In fact, three of these toxins were found in the
venom of the African tarantula Ceratogyrus marshalli:
β-theraphotoxin-Cm1a and β-theraphotoxin-Cm1b modu-
late several subtypes of Nav channels (Nav1.1, Nav1.2,
Nav1.4, Nav1.5, and Nav1.8) by shifting the voltage depend-
ence of channel activation to more depolarized potentials
and by blocking the inward component of the sodium
Fig. 5 a. SDS-PAGE gel (18 % acrylamide) showing the protein profiles of P. regalis (Prv), C. darlingi (Cdv) and B. epicureanum (Bev) venoms. Prv*,
Cdv* and Bev* correspond to the venoms under reducing conditions. b. SDS-PAGE gel (14 % acrylamide) showing the protein profiles of the
venoms under reducing conditions. The protein profiles were compared with a broad-range polypeptide standard (St), and the masses of the
molecular weight markers (in kDa) are shown on the left of the gels. Protein bands were visualized with Coomasie blue
García-Arredondo et al. Journal of Venomous Animals and Toxins including Tropical Diseases  (2015) 21:15 Page 7 of 9current, while β-theraphotoxin-Cm2a modulates Nav1.5
and Nav1.8 channels [6]. A more potent immobilization is
promoted by the potassium channel blockers through the
prevention of nerve repolarization; 43 of these toxins have
been reported in ArachnoServer. Moreover, 36 tarantula
toxins have been reported to be irreversible calcium chan-
nel blockers. Some of these toxins can target different types
of channels (Nav, Kv, and/or Cav) and appear to function
through a similar mechanism; they are known as promiscu-
ous toxins [1, 6].
The complexity of tarantula venoms results in a syner-
gistic action that may produce fast paralysis and death in
prey. Therefore, it is probable that the mixture of neuro-
toxins contained in the venom of C. darlingi is not cap-
able of inducing a fast and permanent paralysis like that
of P. regalis. Some tarantula neurotoxins induce revers-
ible paralysis in specific animal models. For example,
U1-theraphotoxin-Cv1a, found in the venom of Core-
miocnemis valida (Singapore brown tarantula), induces
reversible paralysis in crickets, but not in cockroaches
and mice [6]; and huwentoxin-V, purified from the
venom of Selenocosmia huwena (Chinese bird spider),
can reversibly paralyze locusts and cockroaches for sev-
eral hours [21].
Despite the fact that theraphosid spider bites are consid-
ered to be harmless to humans, there is evidence to support
the idea that bites of Poecilotheria spp. are of medical im-
portance [1, 8, 10, 11]. In a recent literature review of bite
reports of Poecilotheria spp., most of them referred to
P. regalis. Symptoms included local swelling, erythema,
and moderate to severe pain. Of these bites, 58 % caused
generalized muscle cramps that began on average 10 h after
the incident and persisted for 1–14 days. Further symptoms
were burning sensation, heat, fever, myalgia, heavy breath-
ing, increased heart rate, and even brief loss of conscious-
ness [11]. A possible explanation for the higher toxicity of
the Poecilotheria species in humans is associated with the
quantity of venom injected.In a comparative study, the quantity of venom milked
from several theraphosid species was compared and it
was observed that an average Poecilotheria species yields
approximately 12 μL more venom than other therapho-
sids [22]. In the present study, the weight of milked
venom was measured and it was observed that B. epicur-
eanum specimens yielded on average approximately
two-fold more venom than P. regalis specimens, while
C. darlingi specimens yielded four-fold less venom than
B. epicureanum specimens. However, there was no sig-
nificant difference in the amount of protein contained in
the venom milked from the three species. It seems that
the protein content is similar, but it is more concen-
trated in C. darlingi venoms. Thus, it is quite possible
that the toxicity of P. regalis venom is due to the mix-
ture of toxins rather than to the quantity of venom
injected.
Many components of animal venoms are used defen-
sively to ward off predators or competitors by inflicting
pain [23]. Depending on the species, tarantula bite vic-
tims experience moderate or severe pain [10, 11]. This
variable symptom may be attributable to a combination
of a mechanical injury caused by the spider’s large fangs,
a slightly acidic pH (usually close to 5), and the presence
of some components such as biogenic amines (serotonin
and histamine), adenosine, adenosine triphosphate, and
inhibitor cystine knot peptides (vanillotoxins and DkTx),
which specifically activate the noxious heat-sensing tran-
sient receptor potentiating (TRP) V1 receptor that is
also the target of capsaicin, the painful toxin in ‘hot’ chili
peppers [1, 23–25].
The formalin test is widely used to evaluate inflammatory
and non-inflammatory pain in rats [14]. The first phase of
the test is believed to result from the direct activation of
primary afferent sensory neurons; this response is associ-
ated with direct activation of TRP channels present in noci-
ceptors [26]. It has been proposed that the second phase
reflects the combined effects of TRP channel activation and
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longs the pain triggered by mediators such as interleukins
1β, 6, and 8, TNF-α, eicosanoids, and nitric oxide [27, 28].
In this study, the results obtained in the formalin test indi-
cated that the P. regalis, C. darlingi, and B. epicureanum
venoms did not produce a significant nociceptive effect at
the tested doses. However, all three venoms tested in this
study induced inflammatory responses. Similar results were
observed with the venom of the Brazilian theraphosid
spider Acanthoscurria paulensis [29]. The weak nociceptive
responses observed with these venoms may be due to the
presence of analgesic toxins.
In contrast with theraphosid toxins that induce pain by
activating TRPV1 receptors, there are other theraphosid
toxins that have analgesic properties. For example,
μ-TRTX-Hhn1b, isolated from the venom of Ornithoc-
tonus hainana, and huwentoxin-IV, isolated from the
venom of Ornithoctonus huwena, are Nav1.7 channel
inhibitors that efficiently alleviate acute inflammatory
pain and chronic neuropathic pain in animals [30, 31].
Mechanotoxin 4, isolated from Grammostola rosea venom,
reduces mechanical and neuropathic pain by blocking
stretch-activated cation channels [32]. Psalmotoxin 1, iso-
lated from the venom of Psalmopoeus cambridgei, has very
potent analgesic properties against thermal, mechanical,
chemical, inflammatory, and neuropathic pain in rodents
by blocking acid-sensing ion channel 1a; this results in the
activation of the enkephalin pathway [33]. Protoxin-I, ob-
tained from the venom of Thrixopelma pruriens, is the first
known peptide antagonist of the nociceptor ion channel
TRPA1 [34].
Enzymes are important components of the venoms of
several animals, and hyaluronidase activity is widely dis-
played in spider venoms [35]. The substrate for hyaluroni-
dases is the hyaluronic acid, a mucopolysaccharide that is
the major constituent of the extracellular matrix [36]. It is
believed that the presence of these enzymes in animal
venoms helps to distribute other venom components by
hydrolyzing connective tissue [35]. In this study, we found
that all three venoms induce hyaluronidase activity. An im-
portant observation is that P. regalis venom induces signifi-
cantly higher hyaluronidase activity, which could be related
to its higher toxicity. We also found that the venoms do
not display phospholipase A2 or caseinolytic activity, in
agreement with previous studies that suggest that neither
phospholipase A nor protease activity is present in taran-
tula venoms [35, 37].
Finally, analysis by electrophoresis reveals that the C. dar-
lingi and P. regalis venoms contain bands in two regions in
different proportions. One region consists of small peptides
(2–15 kDa) that are mainly neurotoxins [1]. The other re-
gion consists of proteins with masses between 40 and
100 kDa comprising hyaluronidases (39–43 kDa) and other
components [38–40]. The profiles of the venoms showedimportant differences in their compositions, mainly in the
venom of B. epicureanum, in which it can be observed that
the profile of this venom change under reducing conditions.
However, further proteomic analysis is necessary to im-
prove these differences.
Conclusions
This study demonstrates that these theraphosid spiders
of different habitats produce venoms with diverse activ-
ities. It is observed that P. regalis venom displays a high
level of hyaluronidase activity, which may be associated
with its potentially medically significant bite.
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